Duc Dang, A., Dinh Vu, T., Hai Vu, H., Thanh Ta, V., Thi Van Pham, A., Thi Ngoc Dang, M., Van Le, B., Huu Duong, T., Van Nguyen, D., Lawpoolsri, S., Chinwangso, P., McLellan, J. S., Hsieh, C., Garcia-Sastre, A., Palese, P., Sun, W., Martinez, J. L., Gonzalez-Dominguez, I., Slamanig, S., Manuel Carreño, J., Tcheou, J., Krammer, F., Raskin, A., Minh Vu, H., Cong Tran, T., Mai Nguyen, H., Mercer, L. D., Raghunandan, R., Lal, M., White, J. A., Hjorth, R., Innis, B. L., & Scharf, R. (2022). safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam. Vaccine, 40(26), 3621–3632. http://access.bl.uk/ark:/81055/vdc_100156444550.0x000001